Search

Your search keyword '"Sveen K"' showing total 81 results
Start Over Author "Sveen K"
81 results on '"Sveen K"'

4. Poster Session: Right ventricular systolic function

Author

Altman, M., primary, Bergerot, C., additional, Thibault, H., additional, Aussoleil, A., additional, Skuldadt Davidsen, E., additional, Barthelet, M., additional, Derumeaux, G. A., additional, Grapsa, J., additional, Zimbarra Cabrita, I., additional, Afilalo, J., additional, Paschou, S., additional, Dawson, D., additional, Durighel, G., additional, O'regan, D., additional, Howard, L., additional, Gibbs, J., additional, Nihoyannopoulos, P., additional, Morenate Navio, M., additional, Mesa Rubio, M., additional, Ortega, M. D., additional, Ruiz Ortiz, M., additional, Castillo Bernal, F., additional, Del Pino, C. L., additional, Toledano, F., additional, Alvarez-Ossorio, M. P., additional, Ojeda Pineda, S., additional, Lezo Cruz-Conde, J. S. D., additional, Jasaityte, R., additional, Claus, P., additional, Teske, A., additional, Herbots, L., additional, Verheyden, B., additional, Rademakers, F., additional, D'hooge, J., additional, Tocchetti, C. G., additional, Coppola, C., additional, Rea, D., additional, Quintavalle, C., additional, Guarino, L., additional, Castaldo, N., additional, De Lorenzo, C., additional, Condorelli, G., additional, Arra, C., additional, Maurea, N., additional, Voilliot, D., additional, Huttin, O., additional, Camara, Y., additional, Djaballah, W., additional, Carillo, S., additional, Zinzius, P., additional, Sellal, J., additional, Angioi, M., additional, Juilliere, Y., additional, Selton-Suty, C., additional, Dobrowolski, P., additional, Klisiewicz, A., additional, Florczak, E., additional, Prejbisz, A., additional, Szwench, E., additional, Rybicka, J., additional, Januszewicz, A., additional, Hoffman, P., additional, Jurado Roman, A., additional, De Dios Perez, S., additional, De Nicolas, J. M. M., additional, Diaz Anton, B., additional, Rubio Alonso, B., additional, Martin Asenjo, R., additional, Mayordomo Gomez, S., additional, Villagraz Tecedor, L., additional, Blazquez, L., additional, De Meneses, R. T., additional, Bernard, A., additional, Hernandez, A. I., additional, Reynaud, A., additional, Lerclercq, C., additional, Daubert, J., additional, Donal, E., additional, Arjan Singh, R., additional, Sivarani, S., additional, Lim, S., additional, Azman, W., additional, Almeida, M., additional, Cardim, N., additional, Fonseca, V., additional, Carmelo, V., additional, Santos, S., additional, Santos, T., additional, Toste, J., additional, Kosmala, W., additional, Orda, A., additional, Karolko, B., additional, Mysiak, A., additional, Przewlocka-Kosmala, M., additional, Farsalinos, K., additional, Tsiapras, D., additional, Kyrzopoulos, S., additional, Avramidou, E., additional, Vassilopoulou, D., additional, Voudris, V., additional, Hayrapetyan, H., additional, Adamyan, K., additional, Montero Cabezas, J., additional, Granda Nistal, C., additional, Garcia Aranda, B., additional, Sanchez Sanchez, V., additional, Sestito, A., additional, Lamendola, P., additional, Di Franco, A., additional, Lauria, C., additional, Lanza, G., additional, Kukucka, M., additional, Unbehaun, A., additional, Buz, S., additional, Mladenow, A., additional, Kuppe, H., additional, Pasic, M., additional, Habazettl, H., additional, Gemma, D., additional, Montoro Lopez, N., additional, De Celix, M. G. R., additional, Lopez Fernandez, T., additional, De Torres Alba, F., additional, Del Valle, D. I., additional, Ramirez, U., additional, Mesa, J., additional, Moreno Yanguela, M., additional, Lopez Sendon, J., additional, Eveborn, G. W., additional, Schirmer, H., additional, Lunde, P., additional, Heggelund, G., additional, Rasmussen, K., additional, Wang, Z., additional, Lasota, B., additional, Mizia-Stec, K., additional, Mizia, M., additional, Chmiel, A., additional, Adamczyk, T., additional, Chudek, J., additional, Gasior, Z., additional, Venkatesh, A., additional, Johnson, J., additional, Sahlen, A., additional, Brodin, L., additional, Winter, R., additional, Shahgaldi, K., additional, Manouras, A., additional, Valbuena, S., additional, Iniesta, A., additional, Lopez, T., additional, De Torres, F., additional, Salinas, P., additional, Garcia, S., additional, Moreno, M., additional, Lopez-Sendon, J., additional, Lebid, I., additional, Kobets, T., additional, Kuzmenko, T., additional, Katsanos, S., additional, Yiu, K., additional, Clavel, M., additional, Nina Ajmone, N., additional, Van Der Kley, F., additional, Rodes Cabau, J., additional, Schalij, M., additional, Bax, J., additional, Pibarot, P., additional, Delgado, V., additional, Fusini, L., additional, Tamborini, G., additional, Muratori, M., additional, Gripari, P., additional, Marsan, N., additional, Cefalu', C., additional, Ewe, S., additional, Maffessanti, F., additional, Pepi, M., additional, Hasselberg, N., additional, Haugaa, K., additional, Petri, H., additional, Berge, K., additional, Leren, T., additional, Bundgaard, H., additional, Edvardsen, T., additional, Ancona, R., additional, Comenale Pinto, S., additional, Caso, P., additional, Coppola, M., additional, Rapisarda, O., additional, Cavallaro, C., additional, Vecchione, F., additional, D'onofrio, A., additional, Calabro', R., additional, Rimbas, R., additional, Mihaila, S., additional, Enescu, O., additional, Patrascu, N., additional, Dragoi, R., additional, Rimbas, M., additional, Pop, C., additional, Vinereanu, D., additional, Gustafsson, S., additional, Morner, S., additional, Gronlund, C., additional, Suhr, O., additional, Lindqvist, P., additional, Di Bella, G., additional, Zito, C., additional, Minutoli, F., additional, Madaffari, A., additional, Cusma Piccione, M., additional, Mazzeo, A., additional, Massimo, R., additional, Pasquale, M., additional, Vita, G., additional, Carerj, S., additional, Rangel, I., additional, Goncalves, A., additional, Sousa, C., additional, Correia, A., additional, Martins, E., additional, Silva-Cardoso, J., additional, Macedo, F., additional, Maciel, M., additional, Pfeiffer, B., additional, Rigopoulos, A., additional, Seggewiss, H., additional, Alvarez Fuente, M., additional, Sainz Costa, T., additional, Medrano, C., additional, Navarro, M., additional, Blazquez Gamero, D., additional, Ramos, J., additional, Mellado, M., additional, De Jose, M., additional, Munoz, M., additional, Maroto, E., additional, Gargani, L., additional, Gosciniak, P., additional, Pratali, L., additional, Agoston, G., additional, Bruni, C., additional, Guiducci, S., additional, Matucci Cerinic, M., additional, Varga, A., additional, Sicari, R., additional, Picano, E., additional, Zhao, C., additional, Mei, M., additional, Yeung, C., additional, Siu, C., additional, Tse, H., additional, Florescu, M., additional, Magda, L., additional, Mincu, R., additional, Daha, I., additional, Stanescu, C. M., additional, Chirila, L., additional, Baicus, C., additional, Vlase, A., additional, Dan, G., additional, Montoro Lopez, M., additional, Florez Gomez, R., additional, Alonso Ladreda, A., additional, Itziar Soto, C., additional, Rios Blanco, J., additional, Guzman Martinez, G., additional, Lichodziejewska, B., additional, Kurnicka, K., additional, Goliszek, S., additional, Kostrubiec, M., additional, Dzikowska-Diduch, O., additional, Ciurzynski, M., additional, Labyk, A., additional, Krupa, M., additional, Palczewski, P., additional, Pruszczyk, P., additional, De Sousa, C. C., additional, Vigario, A., additional, Pinho, T., additional, Silva Cardoso, J., additional, Park, S.-J., additional, Song, J.-E., additional, Lee, Y.-J., additional, Ha, M.-R., additional, Chang, S.-A., additional, Choi, J.-O., additional, Lee, S.-C., additional, Park, S., additional, Oh, J., additional, Van De Bruaene, A., additional, De Meester, P., additional, Buys, R., additional, Vanhees, L., additional, Delcroix, M., additional, Voigt, J., additional, Budts, W., additional, Blundo, A., additional, Buccheri, S., additional, Monte, I. P., additional, Leggio, S., additional, Tamburino, C., additional, Sotaquira, M., additional, Lang, R., additional, Caiani, E., additional, Floria, M., additional, De Roy, L., additional, Xhaet, O., additional, Blommaert, D., additional, Jamart, J., additional, Gerard, M., additional, Deceuninck, O., additional, Marchandise, B., additional, Seldrum, S., additional, Schroeder, E., additional, Unsworth, B., additional, Sohaib, S., additional, Kulwant-Kaur, K., additional, Malcolme-Lawes, L., additional, Kanagaratnam, P., additional, Malik, I., additional, Ren, B., additional, Mulder, H., additional, Haak, A., additional, Van Stralen, M., additional, Szili-Torok, T., additional, Pluim, J., additional, Geleijnse, M., additional, Bosch, J., additional, Baglini, R., additional, Amaducci, A., additional, D'ancona, G., additional, Van Den Oord, S., additional, Akkus, Z., additional, Ten Kate, G., additional, Renaud, G., additional, Sijbrands, E., additional, De Jong, N., additional, Van Der Lugt, A., additional, Van Der Steen, A., additional, Schinkel, A., additional, Bjallmark, A., additional, Larsson, M., additional, Grishenkov, D., additional, Brodin, L.-A., additional, Brismar, T., additional, Paradossi, G., additional, Sveen, K. A., additional, Nerdrum, T., additional, Hanssen, K., additional, Dahl-Jorgensen, K., additional, Steine, K., additional, Cimino, S., additional, Pedrizzetti, G., additional, Tonti, G., additional, Canali, E., additional, Petronilli, V., additional, Cicogna, F., additional, Arcari, L., additional, De Luca, L., additional, Iacoboni, C., additional, Agati, L., additional, Abdel Moneim, S. S., additional, Eifert Rain, S., additional, Bernier, M., additional, Bhat, G., additional, Hagen, M., additional, Bott-Kitslaar, D., additional, Castello, R., additional, Wilansky, S., additional, Pellikka, P., additional, Mulvagh, S., additional, Delithanasis, I., additional, Celutkiene, J., additional, Kenny, C., additional, Monaghan, M., additional, Park, W., additional, Hong, G., additional, Son, J., additional, Lee, S., additional, Kim, U., additional, Park, J., additional, Shin, D., additional, Kim, Y., additional, Toutouzas, K., additional, Drakopoulou, M., additional, Aggeli, C., additional, Felekos, I., additional, Nikolaou, C., additional, Synetos, A., additional, Stathogiannis, K., additional, Tsiamis, E., additional, Siores, E., additional, Stefanadis, C., additional, Plicht, B., additional, Kahlert, P., additional, Grave, T., additional, Buck, T., additional, Konorza, T., additional, Gursoy, M., additional, Gokdeniz, T., additional, Astarcioglu, M., additional, Bayram, Z., additional, Cakal, B., additional, Karakoyun, S., additional, Kalcik, M., additional, Acar, R., additional, Kahveci, G., additional, Ozkan, M., additional, Tsang, W., additional, Weinert, L., additional, Yurdakul, S., additional, Avci, B., additional, Sahin, S., additional, Dilekci, B., additional, Aytekin, S., additional, Arenga, F., additional, Hascoet, S., additional, Martin, R., additional, Dulac, Y., additional, Peyre, M., additional, Benzouid, C., additional, Hadeed, K., additional, Acar, P., additional, Zakarkaite, D., additional, Skorniakov, V., additional, Zvironaite, V., additional, Grabauskiene, V., additional, Burca, J., additional, Ciparyte, L., additional, Laucevicius, A., additional, Di Salvo, G., additional, Rea, A., additional, D'aiello, A., additional, Del Gaizo, F., additional, Pergola, V., additional, D'andrea, A., additional, Pacileo, G., additional, Calabro, R., additional, Russo, M., additional, Dedobbeleer, C., additional, Hadefi, A., additional, Naeije, R., additional, Unger, P., additional, Mornos, C., additional, Cozma, D., additional, Ionac, A., additional, Mornos, A., additional, Valcovici, M., additional, Pescariu, S., additional, Petrescu, L., additional, Hu, K., additional, Liu, D., additional, Niemann, M., additional, Herrmann, S., additional, Cikes, M., additional, Stoerk, S., additional, Knop, S., additional, Ertl, G., additional, Bijnens, B., additional, Weidemann, F., additional, De Knegt, M., additional, Biering-Sorensen, T., additional, Sogaard, P., additional, Sivertsen, J., additional, Jensen, J., additional, Mogelvang, R., additional, Lam, W., additional, Tang, M., additional, Chan, K., additional, Yang, Y., additional, Fang, F., additional, Sun, J., additional, Yu, C., additional, Lam, Y., additional, Panoulas, V., additional, Sulemane, S., additional, Bratsas, A., additional, Konstantinou, K., additional, Francone, M., additional, Schau, T., additional, Seifert, M., additional, Ridjab, D., additional, Schoep, M., additional, Gottwald, M., additional, Neuss, M., additional, Meyhoefer, J., additional, Zaenker, M., additional, Butter, C., additional, Tarr, A., additional, Stoebe, S., additional, Pfeiffer, D., additional, Hagendorff, A., additional, Maret, E., additional, Ahlander, B.-M., additional, Bjorklund, P.-G., additional, Engvall, J., additional, Staskiewicz, G., additional, Czekajska-Chehab, E., additional, Adamczyk, P., additional, Siek, E., additional, Przybylski, P., additional, Maciejewski, R., additional, Drop, A., additional, Jimenez Rubio, C., additional, Isasti Aizpurua, G., additional, Miralles Ibarra, J., additional, Al-Mallah, M., additional, Somg, T., additional, Alam, S., additional, Chattahi, J., additional, Zweig, B., additional, Dhanalakota, K., additional, Boedeker, S., additional, Ananthasubramaniam, K., additional, Park, C., additional, March, K., additional, Jones, S., additional, Mayet, J., additional, Tillin, T., additional, Chaturvedi, N., additional, Hughes, A., additional, Hamodraka, E., additional, Kallistratos, E., additional, Karamanou, A., additional, Tsoukas, T., additional, Mavropoulos, D., additional, Kouremenos, N., additional, Zaharopoulou, I., additional, Nikolaidis, N., additional, Kremastinos, D., additional, Manolis, A., additional, Loboz-Rudnicka, M., additional, Jaroch, J., additional, Bociaga, Z., additional, Kruszynska, E., additional, Ciecierzynska, B., additional, Dziuba, M., additional, Dudek, K., additional, Uchmanowicz, I., additional, Loboz-Grudzien, K., additional, Silva, D., additional, Magalhaes, A., additional, Jorge, C., additional, Cortez-Dias, N., additional, Carrilho-Ferreira, P., additional, Silva Marques, J., additional, Portela, I., additional, Pascoa, C., additional, Nunes Diogo, A., additional, Brito, D., additional, Roosens, B., additional, Bala, G., additional, Droogmans, S., additional, Hostens, J., additional, Somja, J., additional, Delvenne, E., additional, Schiettecatte, J., additional, Lahoutte, T., additional, Van Camp, G., additional, and Cosyns, B., additional

Published
2012
Full Text
View/download PDF

5. Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097

Author

Fraser, D. A., primary, Diep, L. M., additional, Hovden, I. A., additional, Nilsen, K. B., additional, Sveen, K. A., additional, Seljeflot, I., additional, and Hanssen, K. F., additional

Published
2012
Full Text
View/download PDF

6. Poster Session 1: Thursday 8 December 2011, 08:30-12:30 * Location: Poster Area

Author

Vijayan, S., primary, Khanji, M., additional, Ionescu, A., additional, Vijayan, S., additional, Podoleanu, C., additional, Frigy, A., additional, Ugri, A., additional, Varga, A., additional, Podoleanu, D., additional, Incze, A., additional, Carasca, E., additional, Dobreanu, D., additional, Mjolstad, O., additional, Dalen, H., additional, Graven, T., additional, Kleinau, J., additional, Hagen, B., additional, Fu, H., additional, Liu, T., additional, Li, J., additional, Liu, C., additional, Zhou, C., additional, Li, G., additional, Bordese, R., additional, Capriolo, M., additional, Brero, D., additional, Salvetti, I., additional, Cannillo, M., additional, Antolini, M., additional, Grosso Marra, W., additional, Frea, S., additional, Morello, M., additional, Gaita, F., additional, Maffessanti, F., additional, Caiani, E., additional, Muraru, D., additional, Tuveri, F., additional, Dal Bianco, L., additional, Badano, L., additional, Majid, A., additional, Soesanto, A., additional, Ario Suryo Kuncoro, B., additional, Sukmawan, R., additional, Ganesja, M. H., additional, Benedek, T., additional, Chitu, M., additional, Beata, J., additional, Suciu, Z., additional, Kovacs, I., additional, Bucur, O., additional, Benedek, I., additional, Hrynkiewicz-Szymanska, A., additional, Szymanski, F., additional, Karpinski, G., additional, Filipiak, K., additional, Radunovic, Z., additional, Lande Wekre, L., additional, Steine, K., additional, Bech-Hanssen, O., additional, Rundqvist, B., additional, Lindgren, F., additional, Selimovic, N., additional, Jedrzychowska-Baraniak, J., additional, Jozwa, R., additional, Larysz, B., additional, Kasprzak, J., additional, Ripp, T., additional, Mordovin, V., additional, Ripp, E., additional, Ciobanu, A., additional, Dulgheru, R., additional, Dragoi, R., additional, Magda, S., additional, Florescu, M., additional, Mihaila, S., additional, Rimbas, R., additional, Cinteza, M., additional, Vinereanu, D., additional, Benavides-Vallve, C., additional, Pelacho, B., additional, Iglesias, O., additional, Castano, S., additional, Munoz-Barrutia, A., additional, Prosper, F., additional, Ortiz De Solorzano, C., additional, Manouras, A., additional, Sahlen, A., additional, Winter, R., additional, Vardas, P., additional, Brodin, L., additional, Sarvari, S. I., additional, Haugaa, K. H., additional, Zahid, W., additional, Bendz, B., additional, Aaberge, L., additional, Edvardsen, T., additional, Di Bella, G., additional, Pedri, S., additional, Donato, R., additional, Madaffari, A., additional, Zito, C., additional, Stapf, D., additional, Schreckenberg, M., additional, Carerj, S., additional, Yoshikawa, H., additional, Suzuki, M., additional, Kusunose, Y., additional, Hashimoto, G., additional, Otsuka, T., additional, Nakamura, M., additional, Sugi, K., additional, Grapsa, J., additional, Dawson, D., additional, Gin-Sing, W., additional, Howard, L., additional, Gibbs, J., additional, Nihoyannopoulos, P., additional, Smith, B., additional, Coulter, T., additional, Rendon, A., additional, Gorissen, W., additional, Shiran, A., additional, Asmer, I., additional, Adawi, S., additional, Ganaeem, M., additional, Shehadeh, J., additional, Cameli, M., additional, Lisi, M., additional, Righini, F., additional, Maccherini, M., additional, Sani, G., additional, Galderisi, M., additional, Mondillo, S., additional, Kalimanovska-Ostric, D., additional, Nastasovic, T., additional, Jovanovic, I., additional, Milakovic, B., additional, Dostanic, M., additional, Stosic, M., additional, Sasic, I., additional, Sveen, K., additional, Nerdrum, T., additional, Hanssen, K., additional, Dahl-Jorgensen, K., additional, Holte, E., additional, Vegsundvaag, J., additional, Hole, T., additional, Hegbom, K., additional, Wiseth, R., additional, Ikonomidis, I., additional, Lekakis, J., additional, Tritakis, V., additional, Papadakis, I., additional, Kadoglou, N., additional, Tzortzis, S., additional, Trivilou, P., additional, Koukoulis, C., additional, Paraskevaidis, I., additional, Anastasiou-Nana, M., additional, Smedsrud, M. K., additional, Sarvari, S., additional, Gjesdal, O., additional, Beraldo, M., additional, Solda', E., additional, Cucchini, U., additional, Peluso, D., additional, Tuveri, M., additional, Al Mamary, A., additional, Iliceto, S., additional, Dores, H., additional, Abecasis, J., additional, Carvalho, M., additional, Santos, M., additional, Andrade, M., additional, Ribeiras, R., additional, Reis, C., additional, Horta, E., additional, Gouveia, R., additional, Mendes, M., additional, Zaliaduonyte-Peksiene, D., additional, Mizariene, V., additional, Cesnaite, G., additional, Tamuleviciute, E., additional, Jurkevicius, R., additional, Vaskelyte, J., additional, Zaliunas, R., additional, Smarz, K., additional, Zaborska, B., additional, Jaxa-Chamiec, T., additional, Maciejewski, P., additional, Budaj, A., additional, Trifunovic, D., additional, Sobic-Saranovic, D., additional, Stankovic, S., additional, Ostojic, M., additional, Vujisic-Tesic, B., additional, Petrovic, M., additional, Nedeljkovic, I., additional, Banovic, M., additional, Tesic, M., additional, Petrovic, I., additional, Peovska, I., additional, Srbinovska, E., additional, Maksimovic, J., additional, Andova, V., additional, Arnaudova, F., additional, Hristova, E., additional, Otljanska, M., additional, Vavlukis, M., additional, Jovanova, S., additional, Tamborini, G., additional, Fusini, L., additional, Gripari, P., additional, Muratori, M., additional, Pontone, G., additional, Andreini, D., additional, Bertella, E., additional, Ghulam Ali, S., additional, Bartorelli, A., additional, Pepi, M., additional, Cusma-Piccione, M., additional, Salvia, J., additional, Antonini-Canterin, F., additional, Lentini, S., additional, Donato, D., additional, Miceli, M., additional, Oreto, G., additional, Sachner, R., additional, Rubinshtein, R., additional, Shnapp, M., additional, Gaspar, T., additional, Marchese, A., additional, Deste, W., additional, Sanfilippo, A., additional, Aruta, P., additional, Patane, M., additional, Millan, G., additional, Ussia, G., additional, Tamburino, C., additional, Kujacic, V., additional, Obradovic, S., additional, Crkvenac, Z., additional, Bernard, A., additional, Piquemal, M., additional, Muller, G., additional, Arbeille, P., additional, Charbonnier, B., additional, Broyd, C., additional, Davies, J., additional, Mikhail, G., additional, Mayet, J., additional, Francis, D., additional, Rosca, M., additional, Magne, J., additional, Szymanski, C., additional, Popescu, B., additional, Ginghina, C., additional, Pierard, L., additional, Lancellotti, P., additional, Gonzalez-Mansilla, A., additional, Solis, J., additional, Angulo, R., additional, Perez-David, E., additional, Madrid, G., additional, Garcia-Robles, J., additional, Yotti, R., additional, Prieto, R., additional, Bermejo, J., additional, Fernandez-Aviles, F., additional, Ishikawa, Y., additional, Ishida, T., additional, Osaki, T., additional, Matsuyama, M., additional, Yamashita, H., additional, Ozaki, S., additional, Stevanella, M., additional, Votta, E., additional, Veronesi, F., additional, Alamanni, F., additional, Redaelli, A., additional, Park, S. D., additional, Lee, J., additional, Shin, S., additional, Woo, S., additional, Kim, D., additional, Park, K., additional, Kwan, J., additional, Tsang, W., additional, Chandra, S., additional, Weinert, L., additional, Gayat, E., additional, Djelassi, M., additional, Balbach, T., additional, Mor-Avi, V., additional, Lang, R., additional, De Meester, P., additional, Van De Bruaene, A., additional, Delcroix, M., additional, Budts, W., additional, Abid, L., additional, Frikha, Z., additional, Makni, K., additional, Rekik, H., additional, Znazen, A., additional, Mourad, H., additional, Kammoun, S., additional, Sargento, L., additional, Satendra, M., additional, Sousa, C., additional, Lopes, S., additional, Longo, S., additional, Lousada, N., additional, Palma Reis, R., additional, Fouad, D., additional, Shams Eldeen, R., additional, Beladan, C., additional, Calin, A., additional, Voinea, F., additional, Enache, R., additional, Jurcut, R., additional, Coman, I., additional, Ghionea, M., additional, Djordjevic-Dikic, A., additional, Petrovic, O., additional, Boricic, M., additional, Giga, V., additional, Pisciella, L., additional, Lanzillo, C., additional, Minati, M., additional, Caselli, S., additional, Di Roma, M., additional, Fratini, S., additional, Romano, S., additional, Calo', L., additional, Lioy, E., additional, Penco, M., additional, Finocchiaro, G., additional, Pinamonti, B., additional, Merlo, M., additional, Barbati, G., additional, Sinagra, G., additional, Dilenarda, A., additional, Comenale Pinto, S., additional, Ancona, R., additional, Caso, P., additional, Cavallaro, C., additional, Vecchione, F., additional, D'onofrio, A., additional, Fero', M., additional, Calabro', R., additional, Gustafsson, S., additional, Ihse, E., additional, Henein, M., additional, Westermark, P., additional, Suhr, O., additional, Lindqvist, P., additional, Oliva Sandoval, M., additional, Gonzalez Carrillo, M., additional, Garcia Navarro, M., additional, Garcia-Molina Saez, E., additional, Sabater Molina, M., additional, Saura Espin, D., additional, Lacunza Ruiz, J., additional, Gimeno Blanes, J., additional, De La Morena Valenzuela, G., additional, Valdes Chavarri, M., additional, Prinz, C., additional, Faber, L., additional, Horstkotte, D., additional, Hoetz, H., additional, Voigt, J., additional, Gandara, F., additional, Correia, M., additional, Rosario, I., additional, Fonseca, C., additional, Arroja, I., additional, Aleixo, A., additional, Martins, A., additional, Radulescu, L., additional, Dan Radulescu, D., additional, Parv Andreea, P., additional, Duncea Caius, D., additional, Ciuleanu T, C., additional, Mitrea Paulina, M., additional, Cali Quaglia, F., additional, Ribezzo, M., additional, Boffini, M., additional, Rinaldi, M., additional, Maceira Gonzalez, A. M., additional, Cosin-Sales, J., additional, Dalli, E., additional, Diago, J., additional, Aguilar, J., additional, Ruvira, J., additional, Goncalves, S., additional, Gomes, A., additional, Pinto, F., additional, Tsai, W.-C., additional, Liu, Y.-W., additional, Shih, J.-Y., additional, Huang, Y.-Y., additional, Chen, J.-Y., additional, Tsai, L.-M., additional, Chen, J.-H., additional, Ribeiro, S., additional, Doroteia, D., additional, Santos, L., additional, David, C., additional, Vinhas De Sousa, G., additional, Almeida, A., additional, Iwase, M., additional, Itou, Y., additional, Yasukochi, S., additional, Shiino, K., additional, Inuzuka, H., additional, Sugimoto, K., additional, Ozaki, Y., additional, Gieszczyk-Strozik, K., additional, Sikora-Puz, A., additional, Mizia, M., additional, Lasota, B., additional, Chmiel, A., additional, Lis-Swiety, A., additional, Michna, J., additional, Brzezinska-Wcislo, L., additional, Mizia-Stec, K., additional, Gasior, Z., additional, Luijendijk, P., additional, De Bruin-Bon, H., additional, Zwiers, C., additional, Vriend, J., additional, Van Den Brink, R., additional, Mulder, B., additional, Bouma, B., additional, Brigido, S., additional, Gianfagna, P., additional, Proclemer, A., additional, Plicht, B., additional, Kahlert, P., additional, Kaelsch, H., additional, Buck, T., additional, Erbel, R., additional, Konorza, T., additional, Yoon, H., additional, Kim, K., additional, Ahn, Y., additional, Jeong, M., additional, Cho, J., additional, Park, J., additional, Kang, J., additional, Rha, W., additional, Jansen Klomp, W. W., additional, Brandon Bravo Bruinsma, G., additional, Van 'T Hof, A., additional, Spanjersberg, S., additional, Nierich, A., additional, Bombardini, T., additional, Gherardi, S., additional, Picano, E., additional, Ciarka, A., additional, Herbots, L., additional, Eroglu, E., additional, Van Cleemput, J., additional, Droogne, W., additional, Jasityte, R., additional, Meyns, B., additional, D'hooge, J., additional, Vanhaecke, J., additional, Al Barjas, M., additional, Iskreva, R., additional, Morris, R., additional, Davar, J., additional, Zhao, Y., additional, Holmgren, A., additional, Morner, S., additional, Stepanovic, J., additional, Beleslin, B., additional, Nedeljkovic, M., additional, Mazic, S., additional, Stojanov, V., additional, Piatkowski, R., additional, Kochanowski, J., additional, Scislo, P., additional, Grabowski, M., additional, Marchel, M., additional, Roik, M., additional, Kosior, D., additional, Opolski, G., additional, Tomaszewski, A., additional, Kutarski, A., additional, Tomaszewski, M., additional, Eibel, S., additional, Hasheminejad, E., additional, Mukherjee, C., additional, Tschernich, H., additional, Ender, J., additional, Delithanasis, I., additional, Celutkiene, J., additional, Kenny, C., additional, Monaghan, M., additional, Van Den Oord, S., additional, Ten Kate, G., additional, Akkus, Z., additional, Renaud, G., additional, Sijbrands, E., additional, Ten Cate, F., additional, De Jong, N., additional, Bosch, J., additional, Van Der Steen, A., additional, Schinkel, A., additional, Lisowska, A., additional, Knapp, M., additional, Tycinska, A., additional, Sawicki, R., additional, Kralisz, P., additional, Sobkowicz, B., additional, Chang, S.-A., additional, Lee, S.-C., additional, Kim, E.-Y., additional, Hahm, S.-H., additional, Ahn, G.-T., additional, Sohn, M.-K., additional, Park, S.-J., additional, Choi, J.-O., additional, Park, S.-W., additional, Oh, J.-K., additional, Gursoy, M. O., additional, Gokdeniz, T., additional, Astarcioglu, M., additional, Bayram, Z., additional, Cakal, B., additional, Karakoyun, S., additional, Kalcik, M., additional, Kahveci, G., additional, Yildiz, M., additional, Ozkan, M., additional, Skidan, V., additional, Borowski, A., additional, Park, M., additional, Thomas, J., additional, Ranjbar, S., additional, Hassantash, S., additional, Karvandi, M., additional, Foroughi, M., additional, Davidsen, E. S., additional, Cramariuc, D., additional, Bleie, O., additional, Gerdts, E., additional, Matre, K., additional, Cusma' Piccione, M., additional, Bagnato, G., additional, Mohammed, M., additional, Piluso, S., additional, Oreto, L., additional, Bitter, T., additional, Carvalho, S., additional, Canada, M., additional, Santisteban Sanchez De Puerta, M., additional, Mesa Rubio, M. D., additional, Ruiz Ortiz, M., additional, Delgado Ortega, M., additional, Pena Pena, M. L., additional, Puentes Chiachio, M., additional, Suarez De Lezo Cruz-Conde, J., additional, Pan Alvarez-Ossorio, M., additional, Mazuelos Bellido, F., additional, Suarez De Lezo Herreros De Tejada, J., additional, Altekin, E., additional, Yanikoglu, A., additional, Karakas, S., additional, Oncel, C., additional, Akdemir, B., additional, Belgi Yildirim, A., additional, Cilli, A., additional, Yilmaz, H., additional, Lenartowska, L., additional, Furdal, M., additional, Knysz, B., additional, Konieczny, A., additional, Lewczuk, J., additional, Severino, S., additional, Cavallaro, M., additional, Coppola, M., additional, Motoki, H., additional, To, A., additional, Bhargava, M., additional, Wazni, O., additional, Marwick, T., additional, Klein, A., additional, Sinkovskaya, E., additional, Horton, S., additional, Abuhamad, A., additional, Mingo Santos, S., additional, Monivas Palomero, V., additional, Beltran Correas, B., additional, Mitroi, C., additional, Gutierrez Landaluce, C., additional, Garcia Lunar, I., additional, Gonzalez Mirelis, J., additional, Cavero, M., additional, Segovia Cubero, J., additional, Alonso Pulpon, L., additional, Gurel, E., additional, Karaahmet, T., additional, Tigen, K., additional, Kirma, C., additional, Dundar, C., additional, Pala, S., additional, Isiklar, I., additional, Cevik, C., additional, Kilicgedik, A., additional, Basaran, Y., additional, Brambatti, M., additional, Romandini, A., additional, Barbarossa, A., additional, Molini, S., additional, Urbinati, A., additional, Giovagnoli, A., additional, Cipolletta, L., additional, Capucci, A., additional, Park, S., additional, Choi, E., additional, Ahn, C., additional, Hong, S., additional, Kim, M., additional, Lim, D., additional, Shim, W., additional, Xie, J., additional, Fang, F., additional, Zhang, Q., additional, Chan, J., additional, Yip, G., additional, Sanderson, J., additional, Lam, Y., additional, Yan, B., additional, Yu, C., additional, Jorge Perez, P., additional, De La Rosa Hernandez, A., additional, Hernandez Garcia, C., additional, Duque Garcia, A., additional, Barragan Acea, A., additional, Arroyo Ucar, E., additional, Jimenez Rivera, J., additional, Lacalzada Almeida, J., additional, Laynez Cerdena, I., additional, Carminati, C., additional, Capoulade, R., additional, Larose, E., additional, Clavel, M., additional, Dumesnil, J., additional, Arsenault, M., additional, Bedard, E., additional, Mathieu, P., additional, Pibarot, P., additional, Gargani, L., additional, Baldi, G., additional, Forfori, F., additional, Caramella, D., additional, D'errico, L., additional, Abramo, A., additional, Sicari, R., additional, Giunta, F., additional, Lee, W.-N., additional, Larrat, B., additional, Messas, E., additional, Pernot, M., additional, Tanter, M., additional, Velagic, V., additional, Cikes, M., additional, Matasic, R., additional, Skorak, I., additional, Samardzic, J., additional, Puljevic, D., additional, Lovric Bencic, M., additional, Biocina, B., additional, Milicic, D., additional, Roosens, B., additional, Bala, G., additional, Droogmans, S., additional, Hostens, J., additional, Somja, J., additional, Delvenne, E., additional, Schiettecatte, J., additional, Lahoutte, T., additional, Van Camp, G., additional, Cosyns, B., additional, Ghosh, A., additional, Hardy, R., additional, Chaturvedi, N., additional, Deanfield, J., additional, Pellerin, D., additional, Kuh, D., additional, Hughes, A., additional, Malmgren, A., additional, Dencker, M., additional, Stagmo, M., additional, Gudmundsson, P., additional, Seo, Y., additional, Ishizu, T., additional, Aonuma, K., additional, Schuuring, M. J., additional, Vis, J., additional, Van Dijk, A., additional, Van Melle, J., additional, Pieper, P., additional, Vliegen, H., additional, Sieswerda, G., additional, Foukarakis, E., additional, Pitarokilis, A., additional, Kafarakis, P., additional, Kiritsi, A., additional, Klironomos, E., additional, Manousakis, A., additional, Fragiadaki, X., additional, Papadakis, E., additional, and Dermitzakis, A., additional

Published
2011
Full Text
View/download PDF

10. Comparative mitogenicity and polyclonal B cell activation capacity of eight oral or nonoral bacterial lipopolysaccharides in cultures of spleen cells from athymic (<em>nulnu-BALB/c) and thymic (BALB/c) mice.

Author

Sveen, K. and Skaug, N.

Subjects
*HEMATOPOIETIC system, *FUSOBACTERIUM, *VEILLONELLA, *ANTIGEN presenting cells, *MITOGENS, *PERIODONTAL disease
Abstract

Optimal stimulatory doses of purified phenol-water extracted lipopolysaccharides (LPS) from 5 selected strains of 3 putative periodontopathogens (Fusobacterium nucleatum, Prevotella intermedia, and Veillonella), 3 strains of 2 nonoral bacterial species (Bacteroides fragilis and Salmonella enteritidis), and pokeweed mitogen (PWM ) iduced significantly higher maximum mitogenic responses and polyclonal Ig production in cultures of unfractionated spleen cells from nu/nu-BALB/c (nude) than from BALB/c (normal) mice. Compared with PWM, the LPS were stronger mitogens showing relative mitogenic capacities B. fragilis LPS> F. nucleatum LPS> S. enteritidis LPS, Veillonella LPS, and P. intermedia LPS B. fragilis LPS was the most and S. enteritidis LPS the least effective polyclonal B cell activator of total Ig, IgG2a, lgG2b, IgG3, IgA, and IgM secretion IgGI was not detected, P. intermedia LPS was the strongest IgA inducer Kinetic observations indicated mitogenic responses and polyclonal B cell activation in a close sequential order in nude and normal cells. The LPS were potent Ag- and T-cell Independent polyclonal B cell activators and LPS of subgingival plaque bacteria may therefore play a nonspecific role in the pathogenesis of periodontal diseases. [ABSTRACT FROM AUTHOR]

Published
1992
Full Text
View/download PDF

12. Penetration of metronidazole into preformed cavities in rabbits.

Author

Hofstad, T. and Sveen, K.

Abstract

The concentration of metronidazole in the exudate of walled off Teflon chambers implanted in rabbits was compared with that of serum. The peak concentration of metronidazole in the exudate following intravenous injection was lower and appeared later than in serum. No accumulation of metronidazole in the exudate was observed after repeated doses of the agent. [ABSTRACT FROM PUBLISHER]

Published
1980

16. High Dose Urography in Patients with Renal Failure: A Double Blind Investigation of Iohexol and Metrizoate

Author

Smith, H.-J., Levorstad, K., Berg, K. J., Rootwelt, K., and Sveen, K.

Abstract

The new non-ionic contrast medium iohexol 350 mg I/ml was compared with the ionic contrast medium metrizoate 350 mg I/ml in a double blind, two-group urographic study performed on 20 patients with stable, impaired renal function. A dose of contrast medium of 500 mg I/kg body weight was given to each patient. Iohexol resulted in significantly fewer subjective adverse reactions than metrizoate. A similar image quality was obtained with the two contrast media. No clinically significant difference existed between the two contrast media with respect to influence on blood pressure, pulse or clinical chemical parameters. A tendency to deterioration of renal function after urography was found in both groups, but no difference of statistical significance existed between the two contrast media with respect to possible nephrotoxicity. Inadequate hydration may have been partly responsible for the nephrotoxic effect of the urographic procedure.

Published
1985
Full Text
View/download PDF

19. Tolerability of iohexol after injection into healthy volunteers

Author

Stormorken H, Andrew E, Levorstad K, Sveen K, Kolmannskog F, Sommerfelt Sc, and Kolbenstvedt A

Subjects
Adult, Male, 030213 general clinical medicine, Platelet Function Tests, Iohexol, Contrast Media, Blood Pressure, 030204 cardiovascular system & hematology, Thyroid Function Tests, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Drug tolerance, Heart Rate, Triiodobenzoic Acids, Heart rate, medicine, Humans, Radiology, Nuclear Medicine and imaging, Blood coagulation test, Hematologic Tests, Radiological and Ultrasound Technology, business.industry, Drug Tolerance, Middle Aged, Contrast medium, Blood pressure, Tolerability, Anesthesia, Injections, Intravenous, Drug Evaluation, Iodobenzoates, Blood Coagulation Tests, business, medicine.drug
Abstract

The effects of iohexol, a new non-ionic contrast medium, after intravenous injection into humans are reported. After injection of small doses into 2 subjects, iohexol was injected intravenously into 20 healthy male volunteers in doses of 125 to 500 mg I/kg body weight. A large number of physiologic, biochemical, hematologic and pharmacokinetic parameters were analysed. The results indicated that iohexol was well tolerated and that clinical trials in patients could be undertaken.

Published
1983

20. Tolerability and diagnostic usefulness of iohexol in urography. An open multicentre clinical trial

Author

Sjöberg S, Sveen K, Sommerfelt Sc, Zachrisson Be, Egeblad M, Levorstad K, Thrane Nielsen N, Jagenburg R, Oldbring J, and Kolbenstvedt A

Subjects
Adult, Male, Time Factors, Urinary system, Iohexol, Prostatic Hyperplasia, Contrast Media, Urinary incontinence, 030204 cardiovascular system & hematology, Hematocrit, 03 medical and health sciences, Electrolytes, 0302 clinical medicine, Triiodobenzoic Acids, medicine, Humans, Radiology, Nuclear Medicine and imaging, 030212 general & internal medicine, Adverse effect, Aged, Clinical Trials as Topic, Radiological and Ultrasound Technology, medicine.diagnostic_test, business.industry, Urography, Middle Aged, Blood Cell Count, Enzymes, Clinical trial, Urinary Incontinence, Tolerability, Urinary Tract Infections, Iodobenzoates, Female, medicine.symptom, business, Nuclear medicine, medicine.drug, Pyelogram
Abstract

The first experience with iohexol in urography in humans is reported. Injection of iohexol in a dose of 200 mg I/kg body weight into 34 patients with normal renal function was followed by only few and slight subjective adverse effects. A large number of laboratory tests revealed no toxic effects. High radiographic contrast was obtained.

Published
1982

23. Raised Serum Levels of Syndecan-1 (CD138), in a Case of Acute Idiopathic Systemic Capillary Leak Syndrome (SCLS) (Clarkson's Disease).

Author

Bøe OW, Sveen K, Børset M, and Druey KM

Subjects
Blood Chemical Analysis, Capillary Leak Syndrome diagnosis, Endothelium, Vascular pathology, Enzyme-Linked Immunosorbent Assay methods, Female, Follow-Up Studies, Humans, Middle Aged, Monitoring, Physiologic methods, Rare Diseases, Risk Assessment, Severity of Illness Index, Treatment Outcome, Capillary Leak Syndrome blood, Capillary Leak Syndrome drug therapy, Endothelium, Vascular physiopathology, Immunoglobulins, Intravenous administration & dosage, Syndecan-1 blood
Abstract

BACKGROUND Systemic capillary leak syndrome (SCLS) (Clarkson's disease) is a rare disorder of unknown etiology, characterized by transient episodes of hypotension, and the microvascular leak of fluids into the peripheral tissues, resulting in edema. Between 80-90% of patients with SCLS have a concomitant monoclonal gammopathy. Although translational in vitro studies have implicated vascular endothelial barrier dysfunction in the etiology of SCLS, the etiology and disease associations in clinical cases remain unknown. CASE REPORT We report a case of SCLS in a 49-year-old woman who initially presented with an upper respiratory tract infection, which was complicated by edema and compartment syndromes in the extremities that required fasciotomies. Serum levels of the cell surface heparan sulfate proteoglycan, syndecan-1 (CD138), a measure of endothelial surface glycocalyx (ESG) damage, were measured by enzyme-linked immunoassay (ELISA), peaked at up to 500 ng/mL (reference range, 50-100 ng/mL) and normalized on disease remission. CONCLUSIONS This case report supports the view that damage to the microvascular endothelium, has a role in the pathogenesis of acute SCLS. This case also indicated that monitoring serum levels of syndecan-1 (CD138) might be used to monitor the progression and resolution of episodes of SCLS.

Published
2018
Full Text
View/download PDF

24. Stimulation of B lymphocytes by lipopolysaccharides from anaerobic bacteria.

Author

Hofstad T, Skaug N, and Sveen K

Subjects
Animals, B-Lymphocytes immunology, Bacteria, Anaerobic, Carbohydrate Sequence, Humans, In Vitro Techniques, Lipid A chemistry, Lipopolysaccharides isolation & purification, Lymphocyte Activation drug effects, Mice, Molecular Sequence Data, Molecular Structure, B-Lymphocytes drug effects, Lipopolysaccharides pharmacology
Abstract

Lipopolysaccharides (LPSs) from anaerobic gram-negative bacteria, including those of low endotoxic activity that are isolated from Bacteroides, Prevotella, and Porphyromonas are potent inducers of DNA replication and polyclonal immunoglobulin production in murine B lymphocytes. The activation is dose-dependent and T cell-independent. Replication of DNA and production of immunoglobulins were also stimulated by lipid A and by the LPS heteropolysaccharide that were isolated by mild acid hydrolysis of the LPSs of Bacteroides fragilis and Fusobacterium nucleatum. Combinations of LPS, lipid A, and acid-degraded polysaccharide amplified the blastogenic response. Antibodies that react with the polysaccharide part of LPSs isolated from members of the Bacteroidaceae are present in healthy human serum.

Published
1993
Full Text
View/download PDF

25. Synergistic effect on blastogenesis in murine spleen cells of lipopolysaccharide, lipid A, and acid-degraded polysaccharide from Fusobacterium nucleatum.

Author

Sveen K and Hofstad T

Subjects
Acetates, Acetic Acid, Animals, Cells, Cultured, Drug Synergism, Hydrolysis, Mice, Mice, Nude, Pokeweed Mitogens immunology, Spleen cytology, Spleen immunology, Fusobacterium immunology, Lipid A immunology, Lipopolysaccharides immunology, Lymphocyte Activation, Polysaccharides, Bacterial immunology
Abstract

Interchangeable combinations of Fusobacterium nucleatum Fev1 lipopolysaccharide (LPS) with its split products by acetic acid hydrolysis, i.e. lipid A (LA) and degraded polysaccharide (PS), amplified the blastogenic response in murine spleen cell cultures as measured by [3H]thymidine uptake. Athymic murine spleen cells precultured with LPS-Fev1 for 48 h (stage 1), washed twice and cultured together with fresh cells and either LA or PS for 72 h (stage 2) gave a synergistic response over that found in spleen cell cultures of thymic mice. Spleen cells pre-cultured with LA or PS and with fresh cells and LPS-Fev1 added to stage 2 cultures gave less significant amplification compared with precultures of LPS and either LA or PS together with fresh cells added to stage 2. Precultures with LA, PS or LPS-Fev1 and with pokeweed mitogen (PWM) and fresh cells added produced an additional increment of synergy which was most pronounced in spleen cell cultures of normal mice.

Published
1991
Full Text
View/download PDF

26. Blastogenesis and polyclonal immunoglobulin synthesis in murine spleen cells stimulated with lipopolysaccharide, lipid A and acid-degraded polysaccharide from Fusobacterium nucleatum.

Author

Sveen K and Hofstad T

Subjects
Animals, DNA biosynthesis, Kinetics, Lipid A immunology, Mice, Mice, Inbred BALB C, Mice, Nude, Polysaccharides, Bacterial immunology, Spleen cytology, Spleen immunology, Fusobacterium immunology, Immunoglobulins biosynthesis, Lipopolysaccharides immunology, Lymphocyte Activation, Lymphocytes immunology
Abstract

Lipopolysaccharide of Fusobacterium nucleatum strain Fevl was split by acid hydrolysis. The split products, i.e. lipid A and degraded polysaccharide were mitogenic for murine spleen cells as measured by uptake of [3H]thymidine. The uptake of [3H]thymidine was dose-dependent. Incubation of spleen cells with stimulants for 3 days resulted in a polyclonal activation of immunoglobulin synthesis. Higher mitogenic response and immunoglobulin production were found in spleen cells of athymic mice compared to those of thymic mice. The activity of lipid A in stimulating immunoglobulin synthesis was comparable with the parent lipopolysaccharide-Fevl, the degraded polysaccharide being the less potent stimulator.

Published
1990
Full Text
View/download PDF

27. Giant ranula causing mandibular prognathism.

Author

Sveen K

Subjects
Adult, Diagnosis, Differential, Humans, Male, Mouth Floor pathology, Mouth Floor surgery, Ranula diagnosis, Ranula surgery, Mandibular Diseases etiology, Prognathism etiology, Ranula complications
Abstract

This is a case report of a 20-year-old man with ranula, the size of an orange, in the floor of the mouth causing mandibular prognathism with fan-shaped mandibular teeth anterior to the premolars. The tumor was extirpated. The pathogenesis, differential diagnosis and treatment of ranulas are discussed.

Published
1978
Full Text
View/download PDF

28. Effects of a chemotactic factor and Bacteroides fragilis lipopolysaccharide on bone resorption in tissue culture.

Author

Sveen K

Subjects
Animals, Calcium metabolism, Culture Techniques, Female, Heparin pharmacology, Hydroxyproline metabolism, Lactates metabolism, Parathyroid Hormone pharmacology, Rats, Bacteroides fragilis, Bone Resorption drug effects, Chemotactic Factors pharmacology, Lipopolysaccharides pharmacology
Abstract

Release of previously incorporated 45Ca from fetal rat bone in tissue culture was stimulated by preparations of the polymorphonuclear leukocyte chemotactic factor isolated from lipopolysaccharide (LPS)-induced inflammatory exudate in rabbits as well as by Bacteroides fragilis LPS. High concentrations of released hydroxyproline and lactate seemed to correlate well as a high percentage of 45Ca liberated into the culture medium. An active bone resorption was stimulated by a concentration of 1 microgram/ml of the chemotactic factor. The peak in amount of released 45Ca was at a concentration of 5 micrograms/ml of the chemotactic factor (LPS-CF) as well as of the LPS preparation, whereas the parathyroid hormone was most active at 1 IU/ml. Their effect was connected with the formation of osteoclasts. Neither LPS-CF nor LPS stimulated a release of 45Ca or hydroxyproline from heat-devitalized bones. Heparin added to LPS-CF did not enhance its resorptive potential, whereas when added to LPS it had a synergistic effect. It is suggested that the bone resorptive effect exerted by LPS may be caused by chemotactic factors elaborated by activation of the complement system, and that these factors may be of importance in the pathophysiology of periodontal disease.

Published
1980
Full Text
View/download PDF

29. [Foreign bodies in the maxillary sinus].

Author

Sveen K

Subjects
Female, Foreign Bodies complications, Foreign Bodies diagnostic imaging, Humans, Maxillary Sinus diagnostic imaging, Middle Aged, Radiography, Sinusitis etiology, Surgical Equipment, Foreign Bodies surgery, Maxillary Sinus surgery
Published
1974

30. Incomplete branchial arch syndromes, branchial cleft cyst and vascular hamartoma in a patient with multiple neurofibromatosis.

Author

Vindenes H, Sveen K, and Nilsen R

Subjects
Adult, Branchioma pathology, Branchioma surgery, Facial Asymmetry, Female, Hamartoma pathology, Hamartoma surgery, Humans, Mandibular Neoplasms pathology, Mandibular Neoplasms surgery, Molar surgery, Neurofibromatosis 1 pathology, Neurofibromatosis 1 surgery, Radiography, Panoramic, Syndrome, Tooth Extraction, Branchioma complications, Hamartoma complications, Mandibular Neoplasms complications, Neurofibromatosis 1 complications
Abstract

A case report with simultaneous occurrence of neurofibromatosis, incomplete branchial arch syndromes, a branchial cleft cyst and a pseudocyst in connection with a vascular hamartoma anterior to the right ear of a 38-year-old woman is presented. A possible common pathogenesis of the vascular hamartoma and the incomplete branchial arch syndromes as well as that of the neurofibromatosis is suggested. The pseudocyst is interpreted as a branchial cleft cyst showing inflammatory changes due to a pharyngitis shortly before the preauricular tumor appeared.

Published
1979
Full Text
View/download PDF

32. Rabbit polymorphonuclear leukocyte migration in vitro in response to lipopolysaccharides from Bacteroides, Fusobacterium and Veillonella.

Author

Sveen K

Subjects
Animals, In Vitro Techniques, Lipopolysaccharides isolation & purification, Polysaccharides, Bacterial isolation & purification, Rabbits, Statistics as Topic, Bacteroides, Cell Movement drug effects, Chemotaxis, Leukocyte drug effects, Fusobacterium, Leukocytes drug effects, Lipopolysaccharides pharmacology, Polysaccharides, Bacterial pharmacology, Veillonella
Abstract

Puriified lipopolysaccharides (LPS) from strains of Bacteroides, Fusobacterium and Veillonella incubated with guinea pig serum, were tested for chemotatic activity against rabbit polymorphonuclear leukocytes (PMNs) in modified Boyden chambers. Comparisons were made to a Salmonella LPS (S. enteriditis S-795). Submicrogram amounts of LPS induced positive chemotaxis, and a typical dose-response relationship up to certain dose levels was observed. The difference in chemotactic activity between the Veillonella LPS and LPS-S-795 was not statistically significant. The Fusobacterium LPS showed either a non-significant or a highly significantly lower chemotatic capacity than LPS-S-795. The Bacteroides LPS were also clearly chemotactic, but considerable less when compared to the Salmonella LPS. When serum was not added, the LPS preparation showed no chemotactic activity.

Published
1977
Full Text
View/download PDF

34. Phase II studies in urography, cardioangiography and cerebral angiography with iohexol. An evaluation of the clinical trial program and the clinical findings.

Author

Andrew E, Sveen K, Renaa T, and Dahlstrøm K

Subjects
Adolescent, Adult, Aged, Angiocardiography, Cerebral Angiography, Denmark, Drug Evaluation methods, Drug Evaluation standards, Humans, International Cooperation, Iohexol, Middle Aged, Norway, Research Design standards, Sweden, Urography, Contrast Media toxicity, Iodobenzoates toxicity, Triiodobenzoic Acids toxicity
Abstract

The first experience in patients (phase II studies) with iohexol (Omnipaque) - a new non-ionic contrast medium - in intravenous urography (34 patients), cardioangiography (45 patients) and cerebral angiography (38 patents) is collectively reported. A non-comparative, multicentre design was used in all 3 applications. The objective was to assess the efficacy (the opacity to X-rays) and the tolerability of iohexol using routine contrast medium doses in a well defined adult population. No unexpected or severe reactions occurred in the 117 included or 9 excluded patients. Good efficacy was confirmed, and the contrast medium was well tolerated. The results warrant advancing iohexol into comparative phase III trials. The iohexol phase II studies and initial research in patients with contrast media in general are discussed.

Published
1983

35. [Myxomas in the jaw. A case of bilateral maxillary myxomas].

Author

Sveen K, Bang G, and Gilhuus-moe O

Subjects
Child, Female, Humans, Radiography, Tooth diagnostic imaging, Maxillary Neoplasms diagnosis, Maxillary Neoplasms etiology, Maxillary Neoplasms surgery, Myxoma diagnosis, Myxoma etiology, Myxoma surgery
Published
1975

36. Effect of the addition of a vasoconstrictor to local anesthetic solution on operative and postoperative bleeding, analgesia and wound healing.

Author

Sveen K

Subjects
Adolescent, Adult, Analgesics, Epinephrine therapeutic use, Female, Humans, Intraoperative Complications prevention & control, Male, Postoperative Complications prevention & control, Tooth Extraction, Tooth, Impacted surgery, Anesthesia, Dental, Anesthetics, Local, Oral Hemorrhage prevention & control, Vasoconstrictor Agents therapeutic use, Wound Healing drug effects
Abstract

A clinical study of local anesthetic solutions with and without epinephrine was conducted involving 32 healthy adults requiring removal of bony impacted mandibular third molars. The time elapsing from the administration of the anesthetic solution until analgesia was obtained was significantly shorter in the vasoconstrictor group (P less than 0.001). Additional anesthetic was necessary in 44% of the patients in the control group. The blood loss in the vasoconstrictor group was significantly lower (P less than 0.001) than in the group receiving anesthetic solution without the vasoconstrictor. No statistically significant difference in operation time between the groups was found, although the profuse bleeding in the control group impeded to some extent the surgical procedure. A positive correlation coefficient between operation time and blood loss of r = 0.65 in the vasoconstrictor group (P less than 0.006) and r = 0.77 in the control group (P less than 0.001) was found. Hemorrhage occurring 24 h postoperatively was recorded in 37% of the subjects in the vasoconstrictor group, and of these 83% revealed a healing of the socket by second intention.

Published
1979
Full Text
View/download PDF

37. Randomized double-blind cross-over study of iohexol and Amipaque in cerebral angiography.

Author

Amundsen P, Dugstad G, Presthus J, and Sveen K

Subjects
Adult, Double-Blind Method, Female, Humans, Iohexol, Male, Cerebral Angiography methods, Contrast Media, Iodobenzoates, Metrizamide, Triiodobenzoic Acids
Abstract

Iohexol was compared with Amipaque (metrizamide) in a double-blind study in one pair of injections in each of 20 patients referred for routine cerebral angiography. Catheter position, patient position, injection pressure, contrast medium volume, and concentration (300 mg l/ml) were the same in the two injections, with iohexol and Amipaque being used alternately. Except for these two injections iohexol was used throughout. The parameters studied included diagnostic information obtained (quality of the examination), circulation time, and comparison of patient reactions to the pair of injections (e.g., electrocardiogram, heart rate, and subjective reactions). The patients' reactions to the noncomparative part of the examination were evaluated also, and the patients were observed for possible adverse reactions after the examination. No difference could be detected between the two contrast media in this series. No serious adverse reactions occurred.

Published
1983

38. Clearance of Bacteroides fragilis lipopolysaccharide in vivo.

Author

Sveen K

Subjects
Animals, Bacteroides fragilis, Chemotaxis, Leukocyte, Exudates and Transudates metabolism, Rabbits, Bacteroides Infections metabolism, Lipopolysaccharides metabolism, Polysaccharides, Bacterial metabolism
Abstract

The clearance of bacterial lipopolysaccharide (LPS) from Bacteroides fragilis was studied, using wound chambers implanted subcutaneously in rabbits. The primary skin inflammatory reaction, the Limulus amoebocyte lysate test and the haemagglutination inhibition test all demonstrated a more rapid elimination of LPS from the wound chambers after the second injection, compared to the elimination rate after the first injection given three days earlier. The clearance rate of LPS was significantly higher (0.003 greater than or equal to p greater than or equal to 0.0006) and the number of accumulated leukocytes in the inflammatory exudate significantly lower (p less than or equal to 0.05) after the second injection. Antibodies to B. fragilis LPS in the exudate before the second endotoxin injection was of the 19S IgM class. This suggests that phagocytes in the granulation tissue lining the chamber walls may be of importance in the elimination of endotoxin.

Published
1985
Full Text
View/download PDF

39. Summary of U.S. and European intravascular experience with iohexol based on the clinical trial program.

Author

Dahlstrom K, Shaw DD, Clauss W, Andrew E, and Sveen K

Subjects
Clinical Trials as Topic, Drug Tolerance, Europe, Humans, Iohexol, United States, Contrast Media toxicity, Iodobenzoates, Triiodobenzoic Acids toxicity
Abstract

The nonionic contrast medium, iohexol, was released by Nyegaard, Oslo, in 1980 for clinical testing. Results of a three-phase clinical trial program carried out in Europe and the U.S. through December 1983 are summarized. Evaluation of phase I studies of human tolerance and excretion--and phase II studies of effects on pharmacologic and physiologic parameters--indicated that iohexol was well tolerated and effective. Phase III consisted mainly of controlled parallel and crossover studies comparing iohexol with conventional ionic media and with other nonionic agents in a variety of radiographic studies. Image quality was as good or better with iohexol than with ionic media. Iohexol was tolerated significantly better than ionic agents. Patients consistently reported fewer and less intense pain and heat sensations. Iohexol had less effect on blood pressure, blood flow, heart rate, and electrophysiologic parameters, and caused fewer adverse reactions than ionic media for all types of reactions observed.

Published
1985

40. Chemotaxis or migration inhibition of rabbit peritoneal polymorphonuclear leukocytes caused by chemoattractants at various concentrations.

Author

Sveen K

Subjects
Animals, Ascitic Fluid cytology, Bacteroides fragilis, Cells, Cultured, Culture Media, Dose-Response Relationship, Drug, Rabbits, Veillonella, Cell Migration Inhibition, Chemotactic Factors, Chemotaxis, Leukocyte, Lipopolysaccharides pharmacology, Neutrophils immunology
Abstract

Purified lipopolysaccharide (LPS) from Veillonella incubated in normal rabbit serum was tested for chemotactic activity on rabbit polymorphonuclear leukocytes (PMNs) in modified Boyden chambers. In doses above those giving optimal response (over-optimal dose), a decrease of the PMN migration activity was found. This decrease also correlated well with an increase in the migration inhibition of the PMNs as demonstrated with the capillary tube assay. The PMN chemotactic factor isolated from LPS-induced inflammatory exudate (LPS-CF) in rabbits, produced both a decrease in chemotactic response and a migration inhibition of PMNs in over-optimal doses. This inhibitory effect was not due to cytotoxicity, proved by the trypan blue exclusion test. Also, a reduced locomotion of PMNs first preincubated with chemoattractants and then reactivated, was shown when the same PMNs were restimulated to migration using the same chemoattractants. This was interpreted as a deactivation of the cells. A cross-deactivation was demonstrated between LPS-CF and casein. The results from the experiments reported show that the Boyden chamber may be used to disciminate directional chemotaxis and migration inhibition. It may also be concluded from the study that the reduced migration activity of PMNs at over-optimal doses of chemoattractants is not due to cytotoxicity, but most probably is caused by a deactivation of the cells.

Published
1979
Full Text
View/download PDF

41. [Autotransplantation of teeth: indication, technic and prognosis].

Author

Sveen K and Vindenes H

Subjects
Adolescent, Child, Female, Humans, Male, Prognosis, Radiography, Panoramic, Tooth diagnostic imaging, Tooth Abnormalities surgery, Tooth Exfoliation diagnostic imaging, Tooth Exfoliation surgery, Tooth Extraction, Tooth Replantation methods
Abstract

An account is given of the most important indications for tooth transplantation. The developmental stage of the tooth most suitable for transplantation and the special demands to the recipient site, are considered. Each main group of indication is illustrated with case reports. Finally, factors influencing the prognosis of the transplant are discussed.

Published
1979

42. A polypeptide antigen from a strain of Staphylococcus simulans. 2. Antigenic and biological properties.

Author

Osland A and Sveen K

Subjects
Animals, Antibodies, Bacterial biosynthesis, Cell Migration Inhibition, Chemotaxis, Leukocyte, Complement C4 physiology, Mice, Peptides immunology, Shwartzman Phenomenon, Antigens, Bacterial immunology, Bacterial Proteins immunology, Staphylococcus immunology
Abstract

A purified polypeptide antigen from Staphylococcus simulans CCM 2705 produced one precipitation line by double diffusion in agar with rabbit antiserum against homologous whole bacteria. The purified antigen did not induce antibody production in rabbits. However, when the antigen was complexed with methylated bovine serum albumin, antibodies with specificity against the polypeptide were produced. The antigen did not sensitize normal or tanned erythrocytes for agglutination in antiserum. The polypeptide antigen induced a primary skin reaction and was toxic for mice. It also induced production of MIF as demonstrated by the migration inhibition test. The polypeptide was found to be a leukotaxigen. No difference between C4 normal and C4 deficient serum was noted. C5 was found to be necessary for the induction of chemotaxis.

Published
1981
Full Text
View/download PDF

43. Intravascular studies with iohexol (Omnipaque). Results from the first 49 clinical trials.

Author

Andrew E, Dahlstrøm K, Sveen K, Hvinden G, Holager T, Mowinckel P, Renaa T, and Laulund S

Subjects
Adolescent, Adult, Aged, Angiocardiography, Angiography, Child, Child, Preschool, Clinical Trials as Topic, Female, Humans, Infant, Injections, Intra-Arterial, Injections, Intravenous, Iohexol, Male, Middle Aged, Phlebography, Tomography, Emission-Computed, Triiodobenzoic Acids adverse effects, Urography, Iodobenzoates administration & dosage, Triiodobenzoic Acids administration & dosage
Abstract

In order to assess the vascular clinical trial program of iohexol (Omnipaque) in Europe, the results from the first 49 vascular trials are collectively reported. The included iohexol material comprises 1742 patients. In 40 comparative trials, other contrast media like metrizamide (Amipaque), ioxaglate (Hexabrix) and various monomeric ionic media were administered in 1292 patients included in this analysis. No severe or unexpected adverse reactions related to iohexol were encountered. No clinically significant differences in radiographic image quality between the media were documented. The overall tolerability of iohexol was superior to that of monomeric ionic media and seemed to be as good as that of metrizamide.

Published
1985

44. Paracetamol/codeine in relieving pain following removal of impacted mandibular third molars.

Author

Sveen K and Gilhuus-Moe O

Subjects
Adolescent, Adult, Aspirin therapeutic use, Drug Therapy, Combination, Edema, Female, Humans, Male, Molar, Placebos, Wound Healing, Acetaminophen therapeutic use, Codeine therapeutic use, Pain drug therapy, Tooth Extraction, Tooth, Impacted surgery
Abstract

A double-blind clinical study of analgesic drugs was conducted involving 47 healthy adults requiring removal of 90 bony impacted mandibular third molars. The analgesic effect of paracetamol plus codeine (P + C) 350 + 20 mg was compared to that of acetylsalicylic acid (ASA) 500 mg and placebo. A standardized surgical procedure under local anesthesia was used. Insufficient analgesic effect was noted in 16% of the ASA group and in 69% of the placebo group but in none in the P+C group. On the first postoperative day, patients given P+C suffered less pain compared with those given ASA (P less than 0.01). No relationship could be demonstrated between the type of impaction and intensity of pain. Trismus, however, was found to be associated with difficulty of extirpation. Drowsiness and an increased sleeping tendency were the main side effects found in the P+C group. The incidence of secondary hemorrhage was high in the ASA group, compared with the P+C group a significance of 0.01 less than P less than 0.05 was found on various postoperative days. Registration of swelling revealed less postoperative edema in the P+C group than in the ASA group (0.01less thanPless than0.05). The main conclusion from this study is that the analgesic effect of P+C orally administered after a specific oral surgical procedure is superior to ASA and placebo. P+C also appears to have a more marked antiphologistic effect than ASA.

Published
1975
Full Text
View/download PDF

45. Rabbit polymorphonuclear leukocyte chemotactic factor generated in vivo by Bacteroides fragilis lipopolysaccharide. I. Isolation and physico-chemical characterization.

Author

Sveen K

Subjects
Animals, Bacterial Proteins analysis, Bacteriological Techniques, Cells, Cultured, Chromatography, Gas, Chromatography, Gel, Complement System Proteins analysis, Electrophoresis, Polyacrylamide Gel, Molecular Weight, Neutrophils, Rabbits, Ultracentrifugation, Bacteroides fragilis, Chemotaxis, Leukocyte, Lipopolysaccharides, Peptides analysis, Peptides isolation & purification, Polysaccharides, Bacterial
Abstract

By chromatographic separation on Sephadex gels a peptide, termed the lipopolysaccharide-induced chemotactic factor (LPS-CF), has been isolated from inflammatory exudate. The exudate was obtained from Teflon chambers implanted subcutaneously in rabbits 3 h after LPS from Bacteroides fragilis ss. fragilis had been injected. Three chemotactic peaks were eluted by fractionation of the exudate on Sephadex G-200 columns; one major peak with molecular weight of approximately 16,000 and two minor peaks with molecular weights of approximately 68,000 and 7,000. Refiltration of the major peak on G-75 showed the same elution profile as that found on G-200 columns. By addition of 8 M urea to the elution fluid only the major and the low molecular weight peaks appeared. The molecular weight of the major chemotactic peak was calculated to 16,000 on Sephadex gels, and also using SDS-polyacrylamide gel electrophoresis and equilibrium centrifugation. The chemotactic factor was quite heat-stable and was also non-dialyzable, and freezing and thawing as well as storage at 4 degrees C for several weeks did not impede its activity. This chemotactic factor is probably identical to the cytotaxic fragment split off from C5 upon interaction with LPS.

Published
1978
Full Text
View/download PDF

46. Influence of the cation on the side-effects of urographic contrast media.

Author

Dahl SG, Linaker O, Mellbye A, and Sveen K

Subjects
Adult, Age Factors, Atropine therapeutic use, Body Temperature, Calcium, Drug Hypersensitivity, Female, Histamine H1 Antagonists therapeutic use, Humans, Magnesium, Male, Middle Aged, Nausea chemically induced, Osmolar Concentration, Premedication, Sex Factors, Sodium, Urticaria chemically induced, Diatrizoate analogs & derivatives, Diatrizoate Meglumine adverse effects, Iodobenzoates adverse effects, Metrizoic Acid adverse effects, Urography
Abstract

The incidence of side-effects produced by meglumine diatrizoate and meglumine-, meglumine-calcium-, and sodium-calcium-magnesium metrizoate, was compared in 800 urographies. Patients older than 60 years seem to have less side-effects than younger patients. The incidence of sensation of warmth seems to be higher in patients who have had previous urographies, compared to those who are examined for the first time. The incidence of this effect is higher for the sodium-calcium-magnesium salt of metrizoate, than for other salts of metrizoate.

Published
1976
Full Text
View/download PDF

47. Changes of lateral soft tissue profile after surgical correction of mandibular prognathism.

Author

Berge TI and Sveen K

Subjects
Adult, Dental Occlusion, Humans, Mandible physiopathology, Mandible surgery, Movement, Osteotomy, Connective Tissue anatomy & histology, Face anatomy & histology, Prognathism surgery
Abstract

The lateral soft tissue profile was recorded in 10 patients with slight to moderate degrees of mandibular prognathism, preoperatively, and 6 weeks after subcondylar sliding osteotomy had been performed. The recording method was mechanical. Only small and insignificant profile changes were found in the submandibular and occlusal plane regions as well as in the ramus region. The only significant change of profile was found in the mandibular body region, probably as a result of firm connection between soft tissue and underlying distally moved bone. The lack of significant profile change in the osteotomy region was in accordance with subjective observations and was probably due to local remodelling and adaptation processes. The facial width was thus found to be unaltered 6 weeks postoperatively.

Published
1981
Full Text
View/download PDF

48. [Clinical trial of labetalol (Tranedate) in general practice].

Author

Mathisen R and Sveen K

Subjects
Adult, Aged, Clinical Trials as Topic, Diarrhea chemically induced, Drug Eruptions etiology, Female, Humans, Hypertension drug therapy, Male, Middle Aged, Ethanolamines adverse effects, Labetalol adverse effects
Published
1983

49. The chemotactic effect of Bacteroides fragilis lipopolysaccharide.

Author

Hofstad T and Sveen K

Subjects
Animals, Complement C5 immunology, Complement Pathway, Alternative drug effects, Rabbits, Bacteroides fragilis immunology, Chemotactic Factors, Polysaccharides, Bacterial pharmacology
Abstract

The atypical Bacteroides fragilis lipopolysaccharide is chemotactic for polymorphonuclear leukocytes. The chemotactic activity is mediated by complement activated through the alternative pathway. This mediator has been isolated. It is a polypeptide with a molecular weight of 16,000 and is most likely the complement component C5a.

Published
1979
Full Text
View/download PDF

50. Amipaque (metrizamide) in vascular use and use in body cavities: a survey of the initial clinical trials.

Author

Andrew E, Dahlstrøm K, Sveen K, and Renaa T

Subjects
Adult, Child, Clinical Trials as Topic, Double-Blind Method, Humans, Hysterosalpingography, Infant, Knee Joint diagnostic imaging, Pancreas diagnostic imaging, Angiography methods, Metrizamide adverse effects, Phlebography methods, Urography methods
Abstract

A review of the initial 76 clinical trials with Amipaque in vascular radiology and in examinations of the body cavities, mostly performed in the Scandinavian countries, is given. The clinical material presented comprises a total of 2,661 Amipaque examinations, 1,784 examinations performed intravascularly and 515 in body cavities. In addition, 362 vascular examinations with Amipaque in children are presented. Generally, no difference in visualization compared to ionic media was found. However, improved visualization was reported in some few angiographic studies and higher contrast density was indicated in the urograms. Compared to ionic media, Amipaque caused considerably less subjective reactions and less hemodynamic effects. A remarkable reduction in post-phlebographic thrombosis following leg phlebography was found with Amipaque. No death related to Amipaque occurred, and few contrast medium reactions have been recorded. Thus, the good tolerability of the non-ionic Amipaque shown in animal studies has also been confirmed clinically outside the subarachnoid space.

Published
1981
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results